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Abstract: Fucoidans from brown macroalgae have beneficial biomedical properties but their use
as pharma products requires homogenous oligomeric products. In this study, the action of five
recombinant microbial fucoidan degrading enzymes were evaluated on fucoidans from brown
macroalgae: Sargassum mcclurei, Fucus evanescens, Fucus vesiculosus, Turbinaria ornata, Saccharina
cichorioides, and Undaria pinnatifida. The enzymes included three endo-fucoidanases (EC 3.2.1.-GH
107), FcnA2, Fda1, and Fda2, and two unclassified endo-fucoglucuronomannan lyases, FdlA and
FdlB. The oligosaccharide product profiles were assessed by carbohydrate-polyacrylamide gel
electrophoresis and size exclusion chromatography. The recombinant enzymes FcnA2, Fda1, and Fda2
were unstable but were stabilised by truncation of the C-terminal end (removing up to 40% of the
enzyme sequence). All five enzymes catalysed degradation of fucoidans containing α(1→4)-linked
L-fucosyls. Fda2 also degraded S. cichorioides and U. pinnatifida fucoidans that have α(1→3)-linked
L-fucosyls in their backbone. In the stabilised form, Fda1 also cleaved α(1→3) bonds. For the first
time, we also show that several enzymes catalyse degradation of S. mcclurei galactofucan-fucoidan,
known to contain α(1→4) and α(1→3) linked L-fucosyls and galactosyl-β(1→3) bonds in the
backbone. These data enhance our understanding of fucoidan degrading enzymes and their
substrate preferences and may assist development of enzyme-assisted production of defined
fuco-oligosaccharides from fucoidan substrates.
Keywords: fucoidan; endo-fucoidanase; galactofucan; molecular stabilisation; Sargassum mcclurei;
Turbinaria ornata
1. Introduction
Fucoidan polysaccharides are a family of sulphated, fucose-rich polysaccharides uniquely
produced by brown marine macroalgae (seaweeds) and certain marine invertebrates, such as sea
Mar. Drugs 2018, 16, 422; doi:10.3390/md16110422 www.mdpi.com/journal/marinedrugs
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cucumbers [1,2]. In general, fucoidans, also known as fucose-containing sulphated polysaccharides
(FCSPs), consist of a backbone of α-L fucosyl residues linked together by (1→3) and/or
(1→4)-glycoside bonds. The bonds are organised in stretches of α(1→3) or of alternating α(1→3)- and
α(1→4)-glycoside linkages, depending on the macroalgal origin of the fucoidan, i.e., the species, age,
geographical origin, and collection time (season) [3]. The L-fucosyl residues may be sulphated (−SO3−)
at position C2 and/or C4 (rarely at C3). Some fucoidans have fucose, galactose, glucuronic acid or
other mono- and oligosaccharides as short branches [1,4,5]. Galactofucans are the most structurally
diverse group of fucoidans that have been characterised from brown algae to date. The galactofucans
have galactose residues in their backbone or in their branches; the position and number of these
galactose residues depend on the type of algae [6,7].
The structural diversity of fucoidans or FCSPs is very high as both the sulphatation pattern and
the backbone bond pattern of α(1→3) and α(1→4)-glycosidic bonds vary significantly depending on
the fucoidan source. The fucoidan from Fucus vesiculosus, which is available commercially, is known to
be made up of a backbone of repeating disaccharide units of α(1→3)- and α(1→4)-linked sulphated
L-fucosyl residues (C2, C2/C3, C2/C4, C4 sulphatation) [8–10] (Figure 1). Fucoidan from Fucus
evanescens has a similar L-fucosyl backbone of alternating α(1→4) and α(1→3) L-fucosyls with sulphate
substitution at C2. An additional sulphate may occupy position 4 in some of theα(1→3)-linked fucosyls,
and the remaining hydroxyl groups may be randomly acetylated [1] (Figure 1). In contrast, the bonds in
the backbone of the fucoidan from Undaria pinnatifida and Saccharina cichorioides are exclusively α(1→3).
The backbone U. pinnatifida fucoidan is moreover assumed to be rich in 2,4-disulphate substituted
fucosyl residues and to contain some β(1→4)-linked galactosyl residues as branches [11] (Figure 1).
Some fucoidans have even more complex backbone structures as is the case, e.g., for fucoidan from the
brown macroalgae Sargassum mcclurei and Turbinaria ornata commonly found along the Pacific Ocean
coastline of Vietnam. The S. mcclurei fucoidan is essentially a sulphated galactofucan polysaccharide
having both α(1→3) and α(1→4) linked fucosyl residues, as well as galactosyl-β(1→3) links to fucosyl,
and α(1→6) linkages from fucosyl to galactosyl in the reducing end of the backbone (Figure 1).
The fucosyl residues in S. mcclurei fucoidan are moreover differentially sulphated at C2 and/or at
C4 and some of the galactosyl moieties are sulphated at C6 [12] (Figure 1). Fucoidan extracted from
T. ornata collected at Nha-Trang bay, Vietnam, also seems to be a galactofucan. The backbone of
T. ornata fucoidan has thus been proposed to consist of α(1→3)-linked L-fucosyls with galactosyl
branches (Fuc:Gal ≈ 3:1) and has been found to have a high sulphate content of about 25% with
sulphate attached mostly at C2, and to a lesser extent at C4, of both the fucosyl and the galactosyl
residues [13,14] (Figure 1). The biological function of fucoidans in brown macroalgae is uncertain,
but fucoidans have long been known to exert beneficial biological activities including anti-tumorigenic,
immune-modulatory, anti-inflammatory, anti-coagulant and anti-thrombotic effects, as demonstrated
in vitro and in vivo [14–16]. Fucoidan from S. mcclurei, including the unique galactofucan structural
moieties with sulphated α(1→3) L-fucosyl and α(1→4) linked galactosyl residues, have for example
been shown to inhibit colony formation of DLD-1 human colon cancer cells in vitro [12], and crude,
sulphated fucoidan products extracted from F. vesiculosus and Sargassum spp. are known to cause
growth inhibition and apoptosis of melanoma B16 cells in vitro and to enhance the activity of natural
killer cells in vivo in mice resulting in the specific lysis of YAC-1 cells (a murine T-lymphoma cell
line sensitive to natural killer cells) [15]. However, the high molecular weight, irregular structure,
and viscosity of fucoidans are an obstacle for providing homogeneous preparations for soluble and
concentrate pharmaceutical use. One approach to solve this problem is to use enzymes that can
depolymerise the fucoidans providing a preparation that is easier to handle and also with potentially
bioactive properties.
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Figure 1. Representative fucoidan structures of brown macroalgae Fucus evanescens, Fucus vesiculosus, 
Sargassum mcclurei, Turbinaria ornata, Saccharina cichorioides, and Undaria pinnatifida: (A) main chain of 
S. cichorioides composed of α(1→3)-L-fucosyls; (B) main chain of U. pinnatifida fucoidan also composed 
of α(1→3)-L-fucosyls; (B’) branches of U. pinnatifida fucoidan [11]; (C) main chain of F. evanescens [1] 
and F. vesiculosus fucoidan [8–10], both composed of α(1→3)- and α(1→4)-linked L-fucosyls; (D) main 
chain of T. ornata fucoidan composed of α(1→3)-L-fucosyls [13,14]; (D’) branches of T. ornata of 
α(1→3)-L-fucosyls or of β(1→4)galactosyls and mixed fucosyl-galactosyls; (E) main chain of S. 
mcclurei fucoidan made up of mainly α(1→3)-L-fucosyls [12]; and (E’) branches or inserts in the main 
chain of S. mcclurei fucoidan. In all fucoidan structures: R1: −H or −SO3−; R2: −H, −SO3− or H3COC−; R3: 
SO3−, H3COC− or branches; and R4: SO3− or branches. 
Figure 1. Representative fucoidan structures of brown macroalgae Fucus evanescens, Fucus vesiculosus,
Sargassum mcclurei, Turbinaria ornata, Saccharina cichorioides, and Undaria pinnatifida: (A) main chain of
S. cichorioides composed of α(1→3)-L-fucosyls; (B) main chain of U. pinnatifida fucoidan also composed
of α(1→3)-L-fucosyls; (B’) branches of U. pinnatifida fucoidan [11]; (C) main chain of F. evanescens [1]
and F. vesiculosus fucoidan [8–10], both composed of α(1 3)- and α(1→4)-linked L-fucosyls; (D) main
chain of T. ornata fucoidan composed of α(1 3)-L-fucosyls [13,14]; (D’) branches of T. ornata of
α(1→3)-L-fucosyls or f β(1→4)galactosyls and mixed fucosyl-galactosyls; (E) main chain of S. mcclurei
fucoidan made up of mainly α(1→3)-L-fucosyls [12]; and (E’) branches or inserts i the main ch i of
S. mcclurei fucoidan. In all fucoidan structures: R1: −H or −SO3−; R2: −H, −SO3− or H3COC−; R3:
SO3−, H3COC− or branches; and R4: SO3− or branches.
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About 20 microorganisms, mainly marine bacteria, have been described that produce
fucoidanases [17–21]. In addition, a few fucoidanases have been found in marine molluscs [22,23].
In 2006, the gene encoding a fucoidanase from the marine bacterium Mariniflexile fucanivorans SW5T
was cloned and the recombinant enzyme named FcnA. A C-terminal truncated version of FcnA named
FcnA2 was previously reported to exert endo α(1→4) action on fucoidan from Pelvetia canaliculata
(a type of fucoidan encompassing both α(1→4) and α(1→3) fucosyl-linkages in the backbone) [24].
In 2002, the genes encoding for two endo-fucoidanases referred to as Fda1 and Fda2, from the marine
bacterium Alteromonas sp. SN-1009 were sequenced and their use for degradation of sulphated fucoidan
originating from the brown seaweed Kjellmaniella crassifolia (now called Saccharina sculpera) were
patented [25]. In the patent, these enzymes were reported to catalyse cleavage of α(1→3)-glycosidic
bonds in the K. crassifolia (S. sculpera) fucoidan [25]. FcnA, Fda1, and Fda2 all belong to the new
glycoside hydrolase family GH107 in CAZy [26]. In 2017, two endo-fucoidanases, FFA1 and FFA2,
from the marine bacterium Formosa algae (KMM 3553T) were characterised and also suggested to belong
to GH family 107 [27,28]. The FFA2 enzyme was proposed to be a poly[(1→4)-α-L-fucoside-2-sulphate]
glycano hydrolase [27]. Already in 2003 Sakai et al. reported the finding of a new type of extracellular
endo-fucoidan-lyase activity from “Fucobacter marina” SA-0082, or more correctly Flavobacterium sp.
SA-0082, which acted on sulphated fucoglucurono-mannan from K. crassifolia (S. sculpera) [29,30].
By sequence analyses, it was found that this lyase activity was apparently encoded by two separate
coding regions. Recombinant expression of these two putative fucoidan degrading enzymes, referred
to as FdlA and FdlB, respectively, showed that the two enzymes had about 56% amino acid sequence
identity and both were claimed to act as (glucurono-) fucoidan lyases on K. crassifolia (S. sculpera)
fucoidan [25].
The objective of this work was to compare the catalytic properties, notably the substrate
degradation patterns, on different fucoidans of the three GH107 endo-fucoidanases (EC 3.2.1.-)
referred to as FcnA2, Fda1, and Fda2, and the two enzymes previously reported to be endo-
fucoglucuronomannan-lyases, referred to as FdlA and FdlB. The action of the enzymes on different
fucoidan substrate structures was compared by assessing oligomer product profiles resulting after
treatment with recombinantly produced enzymes on fucoidans originating from six different types of
brown seaweeds: Sargassum mcclurei, Turbinaria ornata, Fucus evanescens, Fucus vesiculosus, Saccharina
cichorioides, and Undaria pinnatifida. We also report stabilisation of the recombinantly produced enzymes
by targeted gene truncation resulting in deletion of large parts of the C-terminal end of several of
the enzymes.
2. Results
2.1. Recombinant Enzyme Expression
The enzymes FcnA2, FdlA and FdlB expressed well and the purified enzymes gave the expected
band sizes as assessed by Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
(Figure 2A). The expression of recombinant Fda1 was high, but the protein remained in the cell debris
after sonication (Figure S1). Several culture conditions for enzyme expression (temperature, medium,
and isopropyl β-D-1-thiogalactopyranoside (IPTG) concentration) were tested to obtain a soluble
enzyme, but without success. Fda2 expressed well, but migrated slower in the SDS-PAGE gel than
expected (94 kDa). At present, the data do not allow any firm conclusions to be drawn regarding
the cause of this retarded migration of the Fda2 protein, but high hydrophobicity and high levels
of charged amino acids may cause anomalous SDS-PAGE migration as compared to the soluble,
commercial protein standards [31]. For the enzymes FcnA2 and Fda2 more than one band was visible
in both the SDS-PAGE gel and in the Western blot (Figure 2), suggesting spontaneous degradation
rather than impurities from other proteins. This observation agrees with previously published data
for recombinantly expressed FcnA2 reporting “co-elution” with other proteins, which could not be
separated by anion exchange or SEC [24]. For the Fda2 enzyme, use of protease inhibitors such as
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PMSF (36978) from Thermo Fisher Scientific (Waltham, MA, USA) and a protease inhibitor cocktail
(P8849) from Sigma-Aldrich (Steinheim, Germany) during purification did not improve stability,
corroborating that the degradation likely occurred during expression in E. coli cells or during the
subsequent purification.
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obtained by C-PAGE indicated more extensive degradation of the fucoidan substrates from 
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obtained show that each enzyme produced differently sized sulphated oligomers in the C-PAGE 
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estern blot of purified FcnA2, FdlA, FdlB, and Fda2. (St) is the protein plus molecular weight marker.
The expected molecular weights of the recombinant enzymes FcnA2, FdlA, FdlB, and Fda2 were 87,
75, 76, and 94 kDa, respectively. The multiple bands seen for FcnA2 and Fda2, notably in the Western
blot, indicate partial degradation of the proteins. Expression of recombinant Fda1 resulted in insoluble
enzyme material which is not shown in this figure.
2.2. Substrate Specificity of the Recombinant Fucoidan-Degrading Enzymes
The six different fucoidan samples were treated with the purified enzymes FcnA2, Fda2, FdlA,
and FdlB and the treatments produced different carbohydrate-polyacrylamide gel electrophoresis
(C-PAGE) patterns with the six fucoidan samples (the expression of recombinant Fda1 resulted in
insoluble enzymes, which is why there are no data for Fda1). The reactions were run for 24 h to ascertain
maximal substrate degradation. Preliminary data using higher enzyme dosage or longer reaction time
did not show higher extent of degradation except of the S. mcclurei fucoidan that gave more visible
bands in the C-PAGE after a 48 h reaction (these data are discussed further below). Hence, the data
obtained by C-PAGE showed both the selectivity and the maximal extent of fucoidan degradation
obtainable for each set of enzyme and substrate. This means that it is presumed that the unreacted
higher molecular weight polysaccharides do not contain structural units, i.e., backbone-stretches,
linkages, substitutions or branches, attackable by the particular enzyme examined. The positive
control standard (St) was the hydrolysate from the enzymatic reaction of the Formosa algae FFA2
on F. evanescens fucoidan, where the lowest band corresponds to a tetra-saccharide of (1→4)- and
(1→3)-linked α-L-fucosyls with each fucosyl residue sulphated at C2 [27] (Figure 3). The data
obtained by C-PAGE indicated more extensive degradation of the fucoidan substrates from Sargassum
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mcclurei (1), Fucus vesiculosus (2), and Fucus evanescens (3) than of substrates predominantly having
α(1→3) glycoside bonds in their backbone structures, originating from Turbinaria ornate (4), Saccharina
cichorioides (5), and Undaria pinnatifida (6), respectively (Figure 3). In general, the data obtained show
that each enzyme produced differently sized sulphated oligomers in the C-PAGE chromatograms,
suggesting that the different enzymes target different linkages and/or differently sulphated fucosyl
residues. The results also suggest that all the enzymes were endo-acting as the enzymatic action left
behind relatively high molecular weight fractions.
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Figure 3. C-PAGE analysis of fucoidan degradation using purified enzy es: (A) substrate control
with no enzyme; and (B–E) enzymatic products from reaction of FcnA2, Fda2, FdlA, and FdlB on
different fucoidans, respectively (expression of recombinant Fda1 resulted in insoluble enzymes, which
is why there are no data for Fda1): (1) Sargassum mcclurei; (2) Fucus vesiculosus; (3) Fucus evanescens;
(4) Turbinaria ornata; (5) Saccharina cichorioides; and (6) Undaria pinnatifida. The extent of degradation is
indicated with: (+++) highest, (++) medium, (+) lowest and (+) is positive activity resulting in a high
molecular smear, while (−) is no activity. The standard (St) is the product profile of FFA2 treatment
of fucoidan from F. evanescens. The lowest band (**) of the St is a tetra-saccharide of (1→4)- and
(1→3)-linked α-L-fucosyls sulphated at every C2 with an approximate mass of 972 Da [27]. (*) indicates
an enzymatic fucoidan degradation product of either lower mass or higher charge than the lowest St
band (**) compound. The reaction time was 24 h.
2.3. FcnA2 Catalyses Cleavage of α(1→4) Fucosyl Bonds in Sulphated Fucoidan Backbones
The recombinantly expressed FcnA2 enzyme exerted highest activity on the fucoidan from
F. evanescens, and the degradation of this substrate was much more profound than on F. vesiculosus,
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even though both substrates have similar alternating α(1→3) and α(1→4) glycoside bonds in the
backbone. The degradation of fucoidan from F. evanescens was in agreement with previous data
showing that FcnA2 is able to degrade fucoidan from Pelvetia canaliculata [24]. The fucoidans from
F. evanescens and P. canaliculata presumably have less if any C2, C4 disulphates in the “−1” position
of the α(1→4)-L-fucosyl linkage compared to the fucoidan substrate from F. vesiculosus, which likely
contains more fucosyl residues with C2/C4 and even some with C2/C3 disulphatation than the
F. evanescens fucoidan. The lesser degree of C2/C4 and C2/C3 disulphatation might be the reason
for the F. evanescens fucoidan being more degraded than the F. vesiculosus fucoidan (Figure 3). Hence,
FcnA2 most likely catalyses cleavage of (1→4)-α-glycosidic bonds between the −1 fucosyl residues
having the sulphate group at C2, but not at both C2, C4. However, detailed structural elucidation
of the fucoidan products and modelling of the substrate accommodation in the enzyme’s active site
are warranted to substantiate this hypothesis. The differences in the degradation of fucoidan from
F. evanescens and F. vesiculosus thus indicate that differences in the sulphatation pattern or in other
types of substitutions on the substrate backbones may influence the action of FcnA2 on these two
Fucus sp. derived fucoidans. The data suggest that the presumed presence in F. vesiculosus of fucosyl
residues with disulphate at C2, C4 (on either the −1 or +1 position of the α(1→4) glycoside bond) may
retard the enzymatic action of FcnA2.
The smallest oligomers released from F. evanescens by FcnA2 also differed from those released
by the FFA2 treatment of fucoidan from F. evanescens in the standard (st) (Figure 3). FFA2 catalyses
the cleavage of (1→4)-α-glycosidic bonds in the F. evanescens fucoidan within the structural fragment
[→3)-α-L-Fucp2S-(1→4)-α-L-Fucp2S-(1→]n but not in the fragment [→3)-α-L-Fucp2S,4S-(1→4)-α-L-
Fucp2S-(1→]n. The difference in the oligomers released suggests that the sulphatation preferences
of the FFA2 and FcnA2 may differ, which invites to further elucidation of the enzyme structures and
detailed analyses and modelling of enzyme-substrate interactions. FcnA2 also catalysed degradation of
the sulphated galacto-fucan fucoidan from S. mcclurei resulting in production of several low molecular
weight bands in the C-PAGE (Figure 3B). The partial degradation is in agreement with the enzyme
attacking α(1→4) linked (sulphated) L-fucosyl residues. Nevertheless, this enzymatic degradation
of S. mcclurei fucoidan is a novel finding, as enzymatic modification of the S. mcclurei fucoidan has
not previously been reported. The apparent lack of action of FcnA2 on the fucoidan from T. ornata,
S. cichorioides, and U. pinnatifida suggests that FcnA2 does not catalyse cleavage of α(1→3) bonds
between fucosyl residues, whereas the activity on the other three substrates supports the hypothesis
that the enzyme attacks α(1→4) bonds between L-fucosyl residues as previously shown [24].
2.4. Fda2 Catalyses Cleavage of α(1→3) Fucosyl Bonds in Sulphated Fucoidan Backbones
Fda2 catalysed partial degradation of the galactofucan-rich fucoidan from S. mcclurei similar to
the action of FcnA2 (Figure 3C). The C-PAGE results showed that this enzyme also exerted partial
degradation of the fucoidans from F. vesiculosus and F. evanescens and had very low activity on the
fucoidans rich in α(1→3) fucosyl linkages from T. ornata, S. cichorioides, and U. pinnatifida. The activity
was very low, but still visible on the S. cichorioides fucoidan (with a smear at the top of the gel
and weak bands in the lower part of the gel) and on the U. pinnatifida fucoidan (with a discernible
smear at the top of the gel) (Figure 2C). The action of Fda2 on S. mcclurei fucoidan is a new finding
which suggests that the Fda2 enzyme may be employed for controlled degradation of the complex
galacto-fucan fucoidan from S. mcclurei. The activity of this enzyme on S. mcclurei, F. evanescens and
F. vesiculosus together with the weak activity observed on substrates rich in α(1→3) fucosyl linkages
corroborates previous claims of the action of Fda2 on α(1→3) bonded L-fucosyls in fucoidan [25]. Both
Fda1 and Fda2 were previously shown to digest sulphated fucans from K. crassifolia (i.e., S. sculpera)
with the backbone structure [3)-α-L-Fucp-(2OSO3)-1→3-α-L-Fucp-(2,4OSO3)-(1→] and to partially
digest fucoidan from other brown algae of the order Laminariales, such as Saccharina japonica, Lessonia
nigrescens, and Ecklonia maxima [32]. The data obtained further support the hypothesis that Fda2, despite
its instability (Figure 2B), catalyses cleavage of α(1→3) fucosyl bonds in sulphated fucoidan backbones.
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2.5. FdlA and FdlB Action
The FdlA and FdlB enzymes originating from Flavobacterium sp. SA-0081 (previously referred
to as “Fucobacter marina”) (Table 1) have been claimed to be specific for certain sulphated
fuco-glucuronomannan (SFGM) structural fragments containing uronic acid and D-mannosyl
α-linkages in fucoidan molecules [25]. The enzymes were purified from the SA-0082 strain and
were shown to catalyse cleavage of SFGM fractions from the brown algae Kjellmaniella crassifolia
(now S. sculpera) via a lyase mechanism cleaving the α-linkage between D-mannosyl and D-glucuronate
in the SFGM fractions [33].
Table 1. Fucoidan-degrading enzymes, features, molecular weight and expression strains used.
Enzyme
Name/GenBank No. Organism Features
a Length (aa) b
Expected
MW
(kDa)
E. coli Expression
Strains
FcnA CAI47003.1 Mariniflexilefucanivorans SW5 nd 1007 nd Nd
FcnA2 Mariniflexilefucanivorans SW5 His6 (N-term) 799 88 BL21 (DE3) pGro7
c
FcnA∆229 Mariniflexilefucanivorans SW5 His10 (N-term) 720 80 BL21 (DE3) pGro7
c
Fda1 AAO00508.1 Alteromonas sp.SN-1009 His10 (N-term) 804 87 BL21 (DE3) pGro7
c
Fda1∆145 Alteromonas sp.SN-1009
His10 (N-term) and
His10 (C-term) 669 73 BL21 (DE3) pGro7
c
Fda1∆395 Alteromonas sp.SN-1009
His10 (N-term) and
His10 (C-term) 419 46 BL21 (DE3) pGro7
c
Fda2 AAO00509.1 Alteromonas sp.SN-1009 His10 (N-term) 868 94 BL21 (DE3) pGro7
c
Fda2-His Alteromonas sp.SN-1009
His10 (N-term) and
His10 (C-term) 878 95 BL21 (DE3) pGro7
c
Fda2∆146 Alteromonas sp.SN-1009
His10 (N-term) and
His10 (C-term) 732 80 BL21 (DE3) pGro7
c
Fda2∆390 Alteromonas sp.SN-1009
His10 (N-term) and
His10 (C-term) 488 53 BL21 (DE3) pGro7
c
FdlA AAO00510.1 Flavobacterium sp.SA-0082 His10 (N-term) 684 74 C41 (DE3)
FdlB AAO00511.1 Flavobacterium sp.SA-0082 His10 (N-term) 692 76 C41 (DE3)
nd, not determined in this study. a Wild type signal peptide had been removed for codon-optimised synthesised
construct; b Includes his-tags; c groES-groEL chaperone expressed from the pGro7 plasmid.
In this study, FdlA and FdlB both exerted activity on the fucoidans from S. mcclurei, F. vesiculosus,
and F. evanescens. Only weak action was observed on fucoidans from T. ornata and essentially no activity
on S. cichorioides and U. pinnatifida was found (Figure 3D,E). Fucoidan preparations from S. mcclurei,
T. ornata, F. evanescens and F. vesiculosus may contain low amounts of uronic acid and sometimes
traces of mannose [12,14,33–35] but until now no data show that D-mannosyl and D-glucuronate are
present in the backbone of these fucoidans. Moreover, no lyase activity was detected by monitoring
absorbance at 232 nm, indicating that the degradation products did not include unsaturated uronic
oligosaccharides. FdlA and FdlB most likely cleave α(1→4) fucosyl bonds in the backbone of these
fucoidans, since lack of activity on fucoidan from S. cichorioides and from U. pinnatifida (and weak
action on T. ornata fucoidan) indicate that FdlA and FdlB do not cleave the α(1→3) bonds in fucoidan.
The similar weak degradation of the fucoidan substrates from F. vesiculosus and F. evanescens by
both enzymes, i.e., producing almost similar oligomer profiles in the C-PAGE, suggests a preference for
rare or complex fucosyl-sulphatation (e.g., C2 and C4) in the Fucus fucoidan substrates. Such substrates
may occur more abundantly in S. mcclurei fucoidan (Figure 2), and the enzyme most likely prefers
to attack only α(1→4) fucosyl-bonds. Enzyme FdlB appeared to exert a more profound action on
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the F. evanescens substrate than FdlA. Interestingly, the action of the two enzymes on S. mcclurei
galacto-fucan substrate produced a band that travelled further in the gel than the sulphated
tetra-saccharide of the control, suggesting that both FdlA and FdlB are able to catalyse disintegration of
sulphated fucoidan oligomers. Due to the high degree of depolymerisation, down to oligosaccharides
of less than DP4 (Figure 3), and due to the high abundance of galactosyl residues in S. mcclurei fucoidan,
we cannot rule out that FdlA and FdlB may cleave galactosyl-α(1→4) bonds (Figure 3D,E), and further
analysis could confirm this conclusion.
2.6. Further Assessment of Sargassum mcclurei Fucoidan Degradation
C-PAGE and SEC of oligosaccharides released by the enzymes FcnA2, Fda2, FdlB and FdlA after
extended reaction for 48 h, showed that each enzyme catalysed profound degradation of S. mcclurei
fucoidan (Figure 4).
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Figure 4. Degradation of Sargas u c l (S. ) by fucoidanas enzymes. (A) C-PAGE;
and (B) size exclusion chromatography (SEC) of the products produced by: (1) FcnA2; ( ) Fda2; (3) FdlA;
and (4) FdlB on S. mcclurei fucoidan and molecular weight standards. The lowest band (**) of the standard
(St), resulting from FFA2 treatment of fucoidan fr m F. ev escens, correspo ds to a tetra- accharide of
(1→4)- and (1→3)-linked α-L-fucosyls with each fucosyl residue sulphated at C2; total mass has been
calculated to be approximately 972 Da [27]. Reaction time was 48 h. (*) indicates an enzymatic fucoidan
degradation product of either lower mass or higher charge than the lowest St band (**) compound.
In all cases, the smallest oligosaccharide ran further than the lowest of the standard, suggesting
that the released oligosaccharides are either smaller or more charged, i.e., more sulphated, than the
tetra-saccharide in the standard. The SEC profiles of the FcnA2 and Fda2 were similar, but the product
profile differed from those of FdlA and FdlB which contained a smaller peak at around 22.5 min
(corresponding to a molecular weight SEC standard of around 1.3 kDa), indicating that they acted
slower if at all on certain fucoidan fragments <1.3 kD. Taken together with the C-PAGE results
(Figure 4A), these data suggest that FdlA and FdlB exerted similar substrate attack preferences and
left behind some oligomers around 1.3 kDa, whereas FcnA2 and Fda2 appeared to degrade the lower
molar weight oligomers to a more significant extent.
2.7. New Construct of FcnA2
Western blot analysis of FcnA2 (Figure 2B) indicated that the spontaneous degradation of FcnA2
occurred from the C-terminal end, since the N-terminal His-tag was still present, making the protein
visible in the Western blot. To avoid this degradation, a further truncation was made by removing
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an additional 80 amino acids from C-terminal end of the FcnA2 protein. This truncated enzyme was
thus 229 amino acids shorter than the original FcnA enzyme and was called FcnA∆229 (Table 1).
FcnA∆229 could be expressed very well and was purified with no apparent protein degradation,
as illustrated by SDS-PAGE and Western blot analysis, giving the expected band size of 80 kDa
(Figure 5A,B). FcnA∆229 showed activity on the same substrates as FcnA2 (Figure 5C).
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plus molecular weight marker; and (C) enzyme activity by C-PAGE of (a) FcnA2 and (b) FcnA∆229
on fucoidans from S. mcclurei, F. vesiculosus and F. evanescens. FcnA2 and FcnA∆229 have similar
profiles on F. vesiculosus and F. evanescens fucoidans. The reaction time was 24 h. The lowest band
(**) of the standard (St), resulting from FFA2 treatment of fucoidan from F. evanescens, corresponds
to a tetra-saccharide of (1→4)- and (1→3)-linked α-L-fucosyls with each fucosyl residue sulphated
at C2; total mass has been calculated to be approximate 972 Da [27]. (*) An oligosaccharide of lower
molecular weight or higher charge than the lowest band in the standard (**).
However, an oligosaccharide was released after 24 h that was running further than what was
observed for FcnA2 (Figure 5C). This result indicated that the change in stability conferred by deletion
of the 80 amino acids in FcnA2 in turn apparently enhanced substrate degradation, but the truncation
did not confer any other apparent changes in the S. mcclurei degradation profile.
2.8. Stabilisation through C-Terminal Truncation of Fda1 and Fda2
The expression of Fda1 was high but the protein remained in the cell debris after sonication
(Figure S1). By sequence analyses of Fda1 and Fda2, it was found that both enzymes contained two
predicted Laminin G domains (IPR001791) (LamG domains) towards the C-terminal of each protein
(Figure S2). Western blot analysis of Fda2 (Figure 2B) also indicated that enzyme destabilisation
occurred via degradation from the C-terminal end as was observed for FcnA2. Hence, a strategy
to stabilise the enzymes by deletion of the two predicted LamG domains in Fda1 and in Fda2 was
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developed and new constructs of Fda1, called Fda1∆145 (one LamG domain deleted) and Fda1∆395
(both LamG domains deleted), were prepared (Table 1). An additional his-tag was included with these
new constructs to ensure better binding to the Ni2+ Sepharose column. Notably for Fda2, in addition
to being highly unstable, substantial amounts of protein were lost during purification, presumably
due to lack of binding to the column (data not shown). This new construct was called Fda2-His
(Table 1). In addition, as for Fda1, new constructs devoid of either one or both of the two predicted
LamG domains of Fda2 were also constructed. These Fda2 C-terminal deletion mutants were named
Fda2∆146 and Fda2∆390 (Table S1 and Figure S2).
SDS-PAGE and Western blot analysis showed that all modified enzyme constructs expressed well.
Some protein degradation was evident, but notably the double LamG deletion constructs, Fda1∆395
and Fda2∆390, appeared more stable than full length enzymes (Figure 6A,B). All the truncated enzymes
exerted activity on S. mcclurei fucoidan, verifying the enzyme stabilisation strategy by LamG deletion
(Figure 6C). Further study verified that Fda1∆395 was stable but that degradation of the other truncated
enzymes (Fda1∆145, Fda2-C-His, Fda2∆146, and Fda2∆390) occurred already inside the E. coli cells,
presumably via action of proteases in E. coli, recognising sites in the C-terminal of the enzymes,
since degradation was evident in the E. coli cells before sonication (Figure S3).Mar. Drugs 2018, 16, x 12 of 19 
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70 kDa respectively. (C) Enzymatic S. cclurei fucoidan (S.m) degradation by C-PAGE: (1) Fda1∆145;
(2) Fda1∆395; (3) Fda2-His; (4) Fda2∆146; (5) Fda2∆390; (6) Fda2; and the standard (St) resulting from
FFA2 treatment of fucoidan from F. evanescens. The lowest band (**) of the standard (St), resulting
from FFA2 treatment of fucoidan from F. evanescens, corresponds to a tetra-saccharide of (1→4)- and
(1→3)-linked α-L-fucosyls with each fucosyl residue sulphated at C2; total mass has been calculated to
be 972 Da [27]. (*) indicates an enzymatic fucoidan degradation product of either lower mass or higher
charge than the lowest St band (**) compound. The reaction time was 48 h.
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2.9. C-Terminally Truncated Fda1 Attacks α(1→3)-Linkages
The truncated Fda1 proteins Fda1∆145 and Fda1∆395 both catalysed degradation of most of the
fucoidan substrates, although compared to the degradation achieved on the S. mcclurei fucoidan,
the extent of degradation appeared to be lower (Figure 7). Both truncated enzymes produced
comparable degradation patterns, releasing fucoidan oligo-saccharides that migrated to the same extent
within the C-PAGE gels. Interestingly, Fda1 mutants were able to catalyse the degradation of fucoidans
rich in α(1→3) fucosyl linkages from T. ornata, S. cichorioides and U. pinnatifida (Figure 7), indicating
that the C-terminally truncated Fda1 enzymes attack α(1→3)-linkages as previously described [25].
Removal of up to 47% of the Fda1 sequence from the C-terminal thus resulted in a more stable enzyme
that retain activity.Mar. Drugs 2018, 16, x 13 of 19 
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3. Discussion
This work showed that different microbially derived fucoidan-degrading enzymes exert activity
on an array of different fucoidan substrates from brown macroalgae, even the very complex S. mcclurei
fucoidan. FcnA2, Fda2, FdlA, and FdlB were found to degrade S. mcclurei fucoidan, with Fda2,
FdlA and FdlB having particularly high activity on this fucoidan, which is known to contain sulphated
galacto-fucan structural units and both α(1→4) and α(1→3) L-fucosyl linkages (Figure 1). FcnA2 and
FcnA2∆229 were more active than all the other enzymes on fucoidan from F. evanescens and they were
also more active on fucoidan from F. evanescens than on fucoidan from F. vesiculosus suggesting an effect
Mar. Drugs 2018, 16, 422 13 of 18
of the substrate sulphatation pattern or of other structural features of the substrate. Fda2 was the only
enzyme that degraded fucoidans rich in α(1→3) L-fucosyl linkages, but FdlA and FdlB were also able
to at least partially degrade the fucoidan from T. ornata. FdlA and FdlB were previously claimed to
be lyases acting on manno-glucurono-linkages in fucoidan from K. crassifolia (i.e., S. sculpera). In the
present work these enzymes were specifically found to act as endo-fucoidanases on fucoidans devoid
of these types of bonds and did not produce any unsaturated 4–5 oligosaccharide uronides.
Enzyme stabilization was successfully achieved by targeted truncation of the C-terminal ends
of FcnA2, Fda1 and Fda2. Interestingly, for FcnA2, the stabilisation by C-terminal truncation, to the
enzyme variant FcnA∆229, resulted in an enzyme which appeared able to foster more profound
degradation of the S. mcclurei fucoidan than the parent enzyme. For Fda1 and Fda2, successful
expression and stabilisation were attained by LamG domain deletion, in turn this stabilisation allowed
us to show the ability of the otherwise unstable Fda1 to catalyse degradation of the S. mcclurei fucoidan.
The data obtained have implications for use of these enzymes, including the stabilised versions,
in fucoidan processing.
Enzymatically produced short sulphated fuco-oligosaccharides, with degree of polymerisation
of 4–10, derived from Sargassum horneri, obtained via treatment with a recombinant GH family
107 endo-fucoidanase, FFA1 (originating from the marine bacterium Formosa algae), were recently
reported unable to suppress growth of DLD-1 human colon cancer cells in vitro, whilst this ability,
i.e., potential anti-cancerogenic activity, is significant for native fucoidan from S. horneri [28]. In contrast,
enzymatically produced sulphated fucoidan products from F. evanescens have been reported to have
a better effect than the corresponding native, higher molecular weight fucoidan, on the functional
activity of innate immunity cells in vitro [36]. Partially depolymerised fucoidan fractions from
Saccharina cichorioides exert strong inhibition of colony formation of colorectal carcinoma cells HT-29
in vitro [37]. It is not yet known whether specific structural units of fucoidan backbones or if particular
sidechains or substitutions on fucoidans confer specific bioactivity functions. The results of the present
work enable targeted production of defined fucoidan oligomer products. The availability of such
homogenous fucoidan oligomers will permit rigorous research studies on the putative pharmaceutical
functions of fucoidans of different structural configurations.
4. Materials and Methods
4.1. Fucoidan Substrates
Crude fucoidans from Sargassum mcclurei, Fucus evanescens, Undaria pinnatifida, and Saccharina
cichorioides were extracted as described by Zvyagintseva et al. (1999) [38]. Fucoidan from S. mcclurei
was purified further by ion-exchange chromatography [12]. Turbinaria ornata fucoidan was extracted
as described by Thanh et al. (2013) [13]. Fucoidans from F. evanescens, U. pinnatifida, and S. cichorioides
were purified as described by Kusaykin et al. (2006) [39]. Pure fucoidan from Fucus vesiculosus (F8190)
was from Sigma-Aldrich (Steinheim, Germany).
4.2. Enzymes and Gene Constructs
Amino acid sequences for the five enzymes FcnA2, the C-terminal truncated version of FcnA
(CAI47003.1) from Mariniflexile fucanivorans SW5 [24]; Fda1 (AAO00508.1) and Fda2 (AAO00509.1)
from Alteromonas sp. SN-1009 (); FdlA (AAO00510.1) and FdlB (AAO00511.1) from Flavobacterium sp.
SA-0082, were retrieved from GenBank (Table 1). The construct containing the gene encoding FcnA2
was designed to harbour an N-terminal 6xhistidine tag, while the gene constructs Fda1, Fda2, FdlA,
and FdlB encoding the Fda1, Fda2, FdlA, FdlB proteins, respectively, were designed to harbour
an N-terminal 10× histidine tag. The synthetic codon-optimised genes (optimised for E. coli expression),
all devoid of their original signal peptide, were synthesised by GenScript (Piscataway, NJ, USA)
and delivered as inserted either into the pET-45b(+) vector between the KpnI and PacI restriction
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sites (FcnA2) or into the pET-19b(+) plasmid vector between the NcoI and XhoI restriction sites
(all other enzymes).
For FcnA2 C-terminal deletion of 80 amino acids of the enzyme equivalent to deletion of 229 amino
acids of FcnA (GenBank No. CAI47003.1) was constructed, and the truncated protein was named
FcnA∆229 (Table 1).
Both Fda1 and Fda2 contain two predicted laminin G (LamG) domains in the sequence. Deletion
mutants devoid of one or both predicted LamG domains were constructed by PCR amplification of the
codon-optimised genes, each with an additional C-terminal 10× histidine tag, using CloneAmp HiFi
polymerase premix (Takara Bio USA Inc., Mountain View, CA, USA) (primer sequences are listed in
Table S1). For Fda1, the truncated proteins were named Fda1∆145 and Fda1∆395, as 145 and 395 amino
acids had been removed from the C-terminal end, respectively. Analogously, for Fda2, the truncated
versions were named Fda2∆146 and Fda2∆390, indicating that 146 and 390 amino acids, respectively,
had been removed from the C-terminal. The construct of Fda2-His was done by adding 10× histidine
tag at the C-terminal end. After PCR amplification, products were digested with BsaI and XhoI and
ligated into the pET19b (+) vector between the NcoI and XhoI sites. Positive clones were confirmed by
DNA sequencing.
The Escherichia coli strain DH5α (Invitrogen® Life Technologies, Thermo Fisher Scientific, Waltham,
MA, USA), was used as plasmid propagation host. BL21 (DE3) and C41 (DE3) (also from Invitrogen®
Life Technologies) were used as expression hosts for the fucoidan-degrading enzymes (Table 1).
Protein expression was done as described below.
4.3. Production of Recombinant Enzymes
Expression of FcnA2 and FcnA∆229 was performed in E. coli (BL21 (DE3) harbouring the Pch2
(pGro7) plasmid. Overnight cultures grown at 37 ◦C with agitation (180 rpm) in lysogeny broth (LB)
medium containing 100 µg mL−1 ampicillin and 34 µg mL−1 chloramphenicol were used to inoculate
500 mL LB containing 100 µg mL−1 ampicillin, 34 µg mL−1 chloramphenicol and 0.05% arabinose.
The inoculated LB was incubated at 37 ◦C with 180 rpm shaking until cultures reached 0.6-0.8 OD600.
Enzyme expression was induced with 1mM IPTG for 20 h at 20 ◦C and 180 rpm.
Expression of Fda1, Fda1∆145, Fda1∆395, Fda2, Fda2-His, Fda2∆146, and Fda2∆390 was also
performed in E. coli (BL21 (DE3) with Pch2 (pGro7)). Overnight cultures grown at 37 ◦C and 180 rpm
in LB medium containing 100 µg mL−1 ampicillin and 34 µg mL−1 chloramphenicol were used to
inoculate 500 mL auto-induction media containing 0.6% Na2HPO4, 0.3% KH2PO4, 2%, tryptone, 5%
yeast extract, 5% NaCl, 0.6% glycerol, 0.05% glucose, 0.2% lactose, 0.05% arabinose, 100 µg mL−1
ampicillin and 34 µg mL−1 chloramphenicol. Cells were grown at 20 ◦C, 180 rpm for 20 h. Expression of
FdlA, FdlB was performed in E. coli (C41 (DE3)). Overnight cultures grown at 37 ◦C and 180 rpm in LB
medium containing 100 µg mL−1 ampicillin were used to inoculate 500 mL LB containing 100 µg mL−1
ampicillin and were grown at 37 ◦C and 180 rpm until cultures reached 0.6-0.8 OD600. The expression
of the recombinant fucoidanases was induced with 1 mM IPTG during cell growth for 20 h at 20 ◦C
and 180 rpm.
Cells were harvested by centrifugation at 5000× g for 20 min and 4 ◦C and the pellet was
re-suspended in binding buffer (20 mM Tris-HCl buffer, 250 mM NaCl, 20 mM imidazole, pH 7.5)
before being disrupted by UP400S Ultrasonic processor (Hielscher, Teltow, Germany)with 0.5 cycle and
100% amplitude. Cell debris was pelleted by centrifugation (20,000× g, 20 min at 4 ◦C). The supernatant
obtained by centrifugation was then filtered through a 0.45 µm filter and applied to a 5 mL Ni2+
Sepharose HisTrap HP column (GE Healthcare, Uppsala, Sweden) which was equilibrated with
binding buffer using an Äkta purifier (GE Healthcare, Uppsala, Sweden). The resin was washed
3 times with 20 mM Tris-HCl buffer, 250 mM NaCl, and 20 mM imidazole at pH 7.5 and proteins were
eluted by a linear gradient of elution buffer (20 mM Tris-HCl buffer, 250 mM NaCl, and 20–500 mM
imidazole, pH 7.5). The eluted fractions were analysed by sodium dodecyl sulphate–polyacrylamide
gel electrophoresis (SDS-PAGE) and Western blotting as described below to assess the purity and
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homogenous fractions were pooled. Protein content was determined by the Bradford assay [40] with
bovine serum albumin as standard.
4.4. SDS-PAGE
The homogeneity and molecular weight of the recombinantly expressed proteins were estimated
by (SDS–PAGE) electrophoresis according to the Laemmli protocol [41]. Electrophoresis was performed
in 12% acrylamide gels with the addition of 4× Laemmli loading-buffer, to 40 µg of crude protein and
5 µg purified protein and 5 mM DTT. The analysis of total intracellular proteins was conducted by using
the biomass from 300 µL culture with 100 µL of 4× Laemmli loading-buffer, 10 µL of samples were
loaded on the 12% acrylamide gels. The Protein Plus molecular weight marker (Bio-Rad Laboratories,
Hercules, CA, USA) with molecular weights of 10–250 kDa was used as standard.
4.5. Western Blot Analysis of Proteins
Total intracellular protein, crude enzymes (40 µg) and pure enzymes (5 µg) were separated
using 12% acrylamide gels with the addition of 4× Laemmli loading-buffer. Separated proteins were
transferred onto a PVDF blotting membrane (GE Healthcare No. 1060022) and blotted in Tris-glycine
pH 8.3 running buffer at 100 V for 45 min, after activation of the membrane in 96% ethanol for around
10 s. The membrane was blocked with 2% skim milk in 0.01 M TBS (Tris-based sodium chloride pH
7.6) buffer containing 0.1% Tween 20 (TBS_T buffer) for 60 min. The membrane was then incubated
in TBS_T buffer with monoclonal anti-polyhistidine peroxidase conjugated antibody (Sigma-Aldrich,
Steinheim, Germany) at 1:10.000 dilutions in a total volume of 30 mL for 1 h. The membrane was
washed in TBS_T buffer 3 × 10 min and TBS with 0.1% Tween20 for 20 min. The bound antibodies
were detected by horse radish peroxidase using the AEC Kit (Sigma-Aldrich, Steinheim, Germany)
according to manufacturer’s protocol.
4.6. Carbohydrate–Polyacrylamide Gel Electrophoresis (C-PAGE)
Reaction mixtures containing 0.5 µg/µL enzyme solution in 20 mM Tris–HCl buffer pH 7.4,
250 mM NaCl and 10 mM CaCl2 (buffer A) and 1% weight/volume fucoidan in buffer A were
incubated at 35 ◦C for 24–48 h. Each reaction mixture (10 µL) was mixed with 5 µL loading buffer (20%
glycerol and 0.02% phenol red). Samples (5 µL) were electrophoresed at 400 V through a 20% (w/v)
1 mm thick resolving polyacrylamide gel with 100 mM Tris-borate buffer pH 8.3 for 1 h. Gel staining
was performed in two steps, first with a solution containing 0.05% alcian blue 8GX (Panreac, Barcelona,
Spain) in 2% acetic acid for 45 min and then with 0.01% O-toluidine blue (Sigma-Aldrich, Steinheim,
Germany) in 50% aqueous ethanol and 1% acid acetic. The hydrolysate standard was obtained after
enzymatic reaction of FFA2 on Fucus evanescens fucoidan [27].
4.7. SEC Analysis
High Performance Size Exclusion Chromatography was performed using an Ultimate iso-3100
SD pump with a WPS-3000 sampler (Dionex, Sunnyvale, CA, USA) connected to an RI-101 refractive
index detector (Shodex, Showa Denko K.K., Tokyo, Japan). One hundred microliters of three times
diluted reaction mixtures were loaded on a Shodex SB-806 HQ GPC column (300 × 8 mm) equipped
with a Shodex SB-G guard column (50 mm × 6 mm) (Showa Denko K.K., Tokyo, Japan). Elution was
performed with 100 mM sodium acetate pH 6 at a flow rate of 0.5 mL/min at room temperature.
Pullunan standards were used as references.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/16/11/422/
s1, Figure S1: Recombinant expression of Fda1 in E. coli. (A) SDS-PAGE; and (B) Western blot of: (1) Autoinduced
cells; (2) the cell debris (after sonication and protein extraction); and (3) crude extract after sonication and
centrifugation. (St) is the protein plus molecular weight marker; Figure S2: Predicted protein domain structures
of Fda1 and Fda2. Domains were predicted using NCBI conserved domain database (cdd) search tool and both
proteins were found to contain two predicted LamG (Laminin G) superfamily domains. In Fda1, the domains
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span from position 429 to 574 aa and from 670 to 809 aa. For Fda2, the domains span from 496 to 641 aa and
from 737 to 876 aa. Arrows indicate the points of truncation. Deletion mutants were named according to deletion
from the C-terminal end, i.e., Fda1∆145, Fda1∆395, Fda2∆146, and Fda2∆390; Figure S3. (A) SDS-PAGE; and (B)
Western blot of induced cells of: (1) Fda1; (2) Fda1∆145; (3) Fda1∆395; (4) Fda2-His; (5) Fda2; (6) Fda2∆146; and (7)
Fda2∆390. St is the protein plus molecular weight marker (Bio-Rad Laboratories, Hercules, CA, USA). Table S1:
Primers for constructing C-terminal deletion mutants.
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